Schrodinger, Inc. (SDGR) stock
SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3044% above fair value
$25.66−1.70 (-6.21%)
Close on Nov 17, 2026Market cap $1.92BP/E –Yield –
Schrodinger revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Schrodinger's revenue for the twelve months ending Jun 30, 2026 was $259.04M, up 8.9% year over year. For fiscal 2025 it was $255.87M, up 23.3% from the year before. The highest annual figure on record is $255.87M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $255.87M | +23.3% |
| FY2024 | Dec 31, 2024 | $207.54M | -4.2% |
| FY2023 | Dec 31, 2023 | $216.67M | +19.7% |
| FY2022 | Dec 31, 2022 | $180.96M | +31.2% |
| FY2021 | Dec 31, 2021 | $137.93M | +27.6% |
| FY2020 | Dec 31, 2020 | $108.10M | +26.4% |
| FY2019 | Dec 31, 2019 | $85.54M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $58.89M | +7.5% |
| Q1 FY2026 | Mar 31, 2026 | $58.59M | -1.6% |
| Q4 FY2025 | Dec 31, 2025 | $87.24M | -1.2% |
| Q3 FY2025 | Sep 30, 2025 | $54.32M | +53.9% |
| Q2 FY2025 | Jun 30, 2025 | $54.76M | +15.7% |
| Q1 FY2025 | Mar 31, 2025 | $59.55M | +62.7% |
| Q4 FY2024 | Dec 31, 2024 | $88.32M | +19.1% |
| Q3 FY2024 | Sep 30, 2024 | $35.29M | -17.1% |
| Q2 FY2024 | Jun 30, 2024 | $47.33M | +34.5% |
| Q1 FY2024 | Mar 31, 2024 | $36.60M | -43.5% |
| Q4 FY2023 | Dec 31, 2023 | $74.13M | +30.4% |
| Q3 FY2023 | Sep 30, 2023 | $42.57M | +15.1% |
| Q2 FY2023 | Jun 30, 2023 | $35.19M | -8.5% |
| Q1 FY2023 | Mar 31, 2023 | $64.78M | +33.1% |
| Q4 FY2022 | Dec 31, 2022 | $56.84M | +23.1% |
| Q3 FY2022 | Sep 30, 2022 | $36.98M | +23.9% |
| Q2 FY2022 | Jun 30, 2022 | $38.47M | +29.2% |
| Q1 FY2022 | Mar 31, 2022 | $48.66M | +51.5% |
| Q4 FY2021 | Dec 31, 2021 | $46.17M | +39.8% |
| Q3 FY2021 | Sep 30, 2021 | $29.85M | +15.7% |
| Q2 FY2021 | Jun 30, 2021 | $29.78M | +29.0% |
| Q1 FY2021 | Mar 31, 2021 | $32.13M | +22.7% |
| Q4 FY2020 | Dec 31, 2020 | $33.03M | +27.9% |
| Q3 FY2020 | Sep 30, 2020 | $25.80M | +29.2% |
| Q2 FY2020 | Jun 30, 2020 | $23.09M | +21.5% |
| Q1 FY2020 | Mar 31, 2020 | $26.17M | +26.2% |
| Q4 FY2019 | Dec 31, 2019 | $25.83M | – |
| Q3 FY2019 | Sep 30, 2019 | $19.96M | – |
| Q2 FY2019 | Jun 30, 2019 | $19.01M | – |
| Q1 FY2019 | Mar 31, 2019 | $20.74M | – |
See a number that looks wrong?